MedinCell S.A.
MDCLFOTCHealthcare● Active
$34.39
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$34.39
52W Low$6.9757
MedinCell S.A. (MDCLF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDCLF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($18.44M) | ($25.04M) | ($32.01M) | ($24.81M) | ($19.02M) |
| Depreciation & Amort. | $1.99M | $1.72M | $1.67M | $1.52M | $1.34M |
| Stock-Based Comp. | $2.96M | $2.81M | $2.28M | $2.39M | $1.56M |
| Change in Working Capital | $24.53M | $3.18M | ($3.04M) | ($2.37M) | $0.62M |
| Net Cash from Operations | $19.46M | ($11.92M) | ($21.00M) | ($21.36M) | ($12.14M) |
| Investing Activities | |||||
| Capital Expenditure | ($1.66M) | ($1.19M) | ($1.03M) | ($1.97M) | ($0.82M) |
| Purchases of Investments | $0.00M | $0.00M | ($0.33M) | ($1.21M) | ($0.28M) |
| Sales of Investments | $0.00M | $0.00M | $2.56M | $1.55M | $0.00M |
| Net Cash from Investing | ($13.21M) | ($0.61M) | $1.30M | ($0.32M) | ($1.06M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | ($0.03M) | $0.00M | ($0.19M) | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($4.11M) | $5.08M | $5.83M | $0.47M | $9.44M |
| Net Cash from Financing | $33.32M | $25.53M | $1.56M | ($0.80M) | $47.92M |
| Free Cash Flow | |||||
| Free Cash Flow | $17.80M | ($13.11M) | ($22.03M) | ($23.34M) | ($12.96M) |
| FCF Margin %(computed) | 69.71% | -143.16% | -221.56% | -570.56% | -158.26% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · M
Explore more MedinCell S.A. data
About MedinCell S.A. (MDCLF) Cash Flow Statement
MedinCell S.A. generated operating cash flow of $0.02B and free cash flow of $0.02B for 2025 — a FCF margin of 69.71%. Capital expenditure was ($0.00B).
Frequently asked questions
MDCLF · 4 questionsMedinCell S.A. generated free cash flow of $0.02B for 2025, up 235.8% year-over-year.
MDCLF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10